X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bortezomib (5) 5
hematology (5) 5
index medicus (5) 5
safety (3) 3
survival (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
cell survival (2) 2
cells (2) 2
chemotherapy (2) 2
dexamethasone (2) 2
female (2) 2
humans (2) 2
melphalan (2) 2
middle aged (2) 2
motivation (2) 2
multiple myeloma (2) 2
multiple myeloma - drug therapy (2) 2
oncology (2) 2
patients (2) 2
prednisone (2) 2
transplants & implants (2) 2
1st-line treatment (1) 1
abridged index medicus (1) 1
adenocarcinoma (1) 1
adult (1) 1
adults (1) 1
aged (1) 1
aged, 80 and over (1) 1
analysis (1) 1
anthracyclines (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
autografts (1) 1
back pain - etiology (1) 1
biopsy (1) 1
blockade (1) 1
bone marrow (1) 1
bone marrow - pathology (1) 1
bone marrow transplantation (1) 1
carcinoma, renal cell - drug therapy (1) 1
carcinoma, renal cell - immunology (1) 1
carcinoma, renal cell - radiotherapy (1) 1
carcinoma, renal cell - secondary (1) 1
carcinoma, renal cell - surgery (1) 1
carolingian (1) 1
clinical trials (1) 1
combined modality therapy (1) 1
corticosteroids (1) 1
cyclophosphamide (1) 1
dexamethasone - administration & dosage (1) 1
dexamethasone - adverse effects (1) 1
diagnosed multiple-myeloma (1) 1
diagnosis (1) 1
disease progression (1) 1
disease-free survival (1) 1
docetaxel (1) 1
doxorubicin (1) 1
drug dosages (1) 1
drug resistance, neoplasm - drug effects (1) 1
efficacy (1) 1
eortc (1) 1
expression (1) 1
follow-up studies (1) 1
fortresses (1) 1
gastric cancer (1) 1
guidelines (1) 1
high-dose dexamethasone (1) 1
high-dose therapy (1) 1
immunochemotherapy (1) 1
improves survival (1) 1
indolent (1) 1
induction (1) 1
inhibit (1) 1
interleukin-6 - blood (1) 1
internal medicine (1) 1
intravenous administration (1) 1
kidney neoplasms - drug therapy (1) 1
kidney neoplasms - immunology (1) 1
kidney neoplasms - surgery (1) 1
kinases (1) 1
lenalidomide (1) 1
lenalidomide maintenance (1) 1
lymphomas (1) 1
maintenance (1) 1
male (1) 1
management (1) 1
mantle cell lymphoma (1) 1
medical services (1) 1
medicine, general & internal (1) 1
medieval (1) 1
meeting abstracts (1) 1
multicenter (1) 1
multiple myeloma - blood (1) 1
multiple myeloma - immunology (1) 1
multiple myeloma - pathology (1) 1
multiple myeloma - urine (1) 1
neoplasm proteins - blood (1) 1
neoplasms, multiple primary - immunology (1) 1
nephrectomy (1) 1
network (1) 1
neutropenia - chemically induced (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Dimopoulos, Meletios A and Dimopoulos, Athanasios and Gay, Francesca and Schjesvold, Fredrik and Beksac, Meral and Hajek, Roman and Weisel, Katja Christina and Weisel, Katja and Goldschmidt, Hartmut and Maisnar, Vladimir and Moreau, Philippe and Min, Chang Ki and Pluta, Andrzej and Pluta, Agnieszka and Chng, Wee Joo and Chng, Wee-Joo and Kaiser, Martin and Zweegman, Sonja and Mateos, Maria-Victoria and Mateos, Maria Victoria and Spencer, Andrew and Iida, Shinsuke and Morgan, Gareth and Suryanarayan, Kaveri and Teng, Zhaoyang and Skacel, Tomas and Palumbo, Antonio and Dash, Ajeeta B and Gupta, Neeraj and Labotka, Richard and Rajkumar, S Vincent and Bar, Daniel and Basso, Alfredo and Fantl, Dorotea and He, Simon and Horvath, Neomi and Lee, Cindy and Lee, Jae Hoon and Rowlings, Phillip and Taylor, Kerry and Cochrane, Tara and Kwok, Fiona and Ramanathan, Sundreswran and Agis, Hermine and Zojer, Niklas and Kentos, Alain and Offner, Fritz and Van Droogenbroeck, Jan and Wu, Ka Lung and Maiolino, Angelo and Martinez, Gracia and Zanella, Karla and Capra, Marcelo and Araújo, Sérgio and Gregora, Evzen and Pour, Ludek and Scudla, Vlastimil and Spicka, Ivan and Abildgaard, Niels and Andersen, Niels and Jensen, Bo Amdi and Helleberg, Carsten and Plesner, Torben and Salomo, Morten and Svirskaite, Asta and Delarue, Richard and Blau, Igor and Schieferdecker, Aneta and Teleanu, Veronica and Munder, Markus and Röllig, Christoph and Salwender, Han-Juergen and Fuhrmann, Stephan and Duerig, Jan and Zeis, Matthias and Klein, Stefan and Reimer, Peter and Schmidt, Christian and Scheid, Christof and Mayer, Karin and Hoffmann, Martin and Sosada, Markus and Delimpasi, Sosana and Kyrtsonis, Mary-Christine and Anagnostopoulos, Achilleas and Nagy, Zsolt and Illés, Árpád and Egyed, Miklós and Borbényi, Zita and Mikala, Gabor and Dally, Najib and Horowitz, Netanel and Gutwein, Odit and Nemets, Anatoly and Vaxman, Iuliana and Shvetz, Olga and Trestman, Svetlana and Ruchlemer, Rosa and Nagler, Arnon and Tadmor, Tamar and ... and TOURMALINE-MM3 Study Grp and TOURMALINE-MM3 study group
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 253 - 264
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3119 - 3119
Introduction: Despite advances in treatment strategy, multiple myeloma (MM) remains a challenging, incurable disease as patients (pts) often relapse. Here we... 
Journal Article
by Robak, Tadeusz and Jin, Jie and Pylypenko, Halyna and Verhoef, Gregor and Siritanaratkul, Noppadol and Drach, Johannes and Raderer, Markus and Mayer, Jiri and Pereira, Juliana and Tumyan, Gayane and Okamoto, Rumiko and Nakahara, Susumu and Hu, Peter and Appiani, Carlos and Nemat, Sepideh and Cavalli, Franco and Van Hoof, Achiel and Sheliga, Adriana and Teixeira, Adriana and Tomita, Akihiro and Rocafiguera, Albert Oriol and Suvorov, Alexander and Kuzmin, Alexy and Khojasteh, Ali and Mezlini, Amel and Golenkov, Anatoly and Bosly, Andre and Belch, Andrew and Van De Velde, Ann and Illes, Árpád and Mukhopadhyay, Ashis and Meddeb, Balkis and De Prijck, Bernard and Garichochea, Bernardo and Undar, Bulent and Gabarrón, Caballero and Cao, Carmen and Souza, Carmino and Farber, Charles and Won Suh, Cheol and Burcoveanu, Cristina Ileana and Cebotaru, Cristina Ligia and Truica, Cristina-Ligia and Maruyama, Dai and Belada, David and Ben Yehuda, Dina and Udovitsa, Dmitry and Dolores and Morra, Enrica and Späth-Schwalbe, Ernst and Gonzalez-Barca, Eva and Osmanov, Evgenii and Capote, Francisco Javier and Offner, Fritz and Cardenas, Galvez and Heß, Georg and Manikhas, Georgii and Babu, Govind and Rekhtman, Grigoriy and Rossi, Guiseppe and Marques, Herlander and Marques, Margarida and Bumbea, Horia and Wang, Zhao and Wang, Huaqing and Huang, Huiqiang and Choi, Ilseung and Bulavina, Irina and Lysenko, Irina and Avivi, Irit and Kryachok, Iryna and Zaucha, Jan Maciej and Novak, Jan and Díaz, Joaquín and Demeter, Judit and Alexeeva, Julia and Zhu, Jun and Vilchevskaya, Kateryna and Ishizawa, Kenichi and Mauricio, Kenny and Tobinai, Kensei and Ando, Kiyoshi and Abdulkadryrov, Kudrat and Shih, Lee-Yung and Kuzina, Lyudmila and Gumus, Mahmut and De Wit, Maike and Capra, Marcelo and Golubeva, Marina and Ojeda-Uribe, Mario and Kyselyova, Maryna and Taniwaki, Masafumi and Federico, Massimo and Crump, Michael and Baccarani, Michele and Ogura, Michinori and Egyed, Miklós and Udvardy, Miklos and Kurosawa, Mitsutoshi and Uike, Naokuni and ... and LYM-3002 investigators
The Lancet Oncology, ISSN 1470-2045, 11/2018, Volume 19, Issue 11, pp. 1449 - 1458
In the LYM-3002 study, the efficacy and safety of frontline bortezomib plus rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) and rituximab,... 
NON-INFERIORITY | TRIAL | 1ST-LINE TREATMENT | IMMUNOCHEMOTHERAPY | MULTICENTER | NETWORK | MANAGEMENT | ONCOLOGY | PLUS RITUXIMAB | GUIDELINES | INDOLENT | Anthracyclines | Cyclophosphamide | Corticosteroids | Bortezomib | Analysis | Prednisone | Steroids
Journal Article
by Mateos, Maria and Mateos, Maria-Victoria and Blacklock, Hilary and Schjesvold, Fredrik and Oriol, Albert and Simpson, David and George, Anupkumar and Goldschmidt, Hartmut and Larocca, Alessandra and Chanan-Khan, Asher and Sherbenou, Daniel and Avivi, Irit and Benyamini, Noam and Iida, Shinsuke and Matsumoto, Morio and Suzuki, Kenshi and Ribrag, Vincent and Usmani, Saad Z and Usmani, Saad and Jagannath, Sundar and Ocio, Enrique M and Rodriguez-Otero, Paula and San Miguel, Jesus and Kher, Uma and Farooqui, Mohammed and Liao, Jason and Marinello, Patricia and Lonial, Sagar and Nicol, Andrew and Grigoriadis, George and Catalano, John and LeBlanc, Richard and Elemary, Mohamed and Bahlis, Nizar and Facon, Thierry and Karlin, Lionel and Attal, Michel and Engelhardt, Monika and Weisel, Katja and Mackensen, Andreas and Nagler, Arnon and Ben Yehuda, Dina and Magen-Nativ, Hila and Palumbo, Antonio and Cavo, Michele and Tobinai, Kensei and Chou, Takaai and Kosugi, Hiroshi and Taniwaki, Masafumi and Sunami, Kazutaka and Ando, Kiyoshi and Ganly, Peter and Gjertsen, Bjorn and Lahuerta, Juan and Blade, Joan and Oriol Rocafiguera, Albert and Larson, Sarah and Atanackovic, Djordje and Devarakonda, Srinivas and Bitran, Jacob and Zonder, Jeffrey and Morganstein, Neil and Hay, Mohammad and Saylors, Gene and Kio, Ebenezer and Oliff, Ira and Kirkel, Dean and Shtivelband, Mikhail and Yuen, Carrie and Yee, Andrew and Shah, Jatin and Htut, Myo and Raza, Shahzad and Chhabra, Saurabh and Stiff, Patrick and Hari, Parameswaran and Bank, Bruce and Malek, Ehsan and Gasparetto, Cristina and Faroun, Ycaoub and Kreisle, William and Singhal, Seema and Rosenblatt, Jacalyn and Lee, Wes and Safah, Hana and Lutzky, Jose and Suh, Jason and Pan, Dorothy and Baron, Ari and Manges, Robert and Steis, Ronald and Oliveira, Moacyr and Moreb, Jan and Callander, Natalie and Anz, Bertrand and Raptis, Anastasios and Stampleman, Laura and Melear, Jason and Boyd, Thomas and Garbo, Lawrence and ... and KEYNOTE-183 Investigators
The Lancet Haematology, ISSN 2352-3026, 09/2019, Volume 6, Issue 9, pp. e459 - e469
Pomalidomide and dexamethasone is a standard of care for patients with multiple myeloma in whom bortezomib and lenalidomide treatment has failed. KEYNOTE-183... 
SURVIVAL | BORTEZOMIB | HEMATOLOGY | DOCETAXEL | HIGH-DOSE DEXAMETHASONE
Journal Article
by Dimopoulos, Meletios A and Gay, Francesca and Schjesvold, Freik and Beksac, Meral and Hajek, Roman and Weisel, Katja Christina and Goldschmidt, Hartmut and Maisnar, Vladimir and Moreau, Philippe and Min, Chang Ki and Pluta, Agnieszka and Chng, Wee-Joo and Kaiser, Martin and Zweegman, Sonja and Mateos, Maria Victoria and Spencer, Anew and Iida, Shinsuke and Morgan, Gareth and Suryanarayan, Kaveri and Teng, Zhaoyang and Skacel, Tomas and Palumbo, Antonio and Dash, Ajeeta B and Gupta, Neeraj and Labotka, Richard and Rajkumar, S. Vincent and Bar, Daniel and Basso, Alfredo and Fantl, Dorotea and He, Simon and Horvath, Neomi and Lee, Cindy and Rowlings, Phillip and Taylor, Kerry and Cochrane, Tara and Kwok, Fiona and Ramanathan, Suneswran and Agis, Hermine and Zojer, Niklas and Kentos, Alain and Offner, Fritz and Van ogenbroeck, Jan and Wu, Ka Lung and Maiolino, Angelo and Martinez, Gracia and Zanella, Karla and Capra, Marcelo and Araujo, Sergio and Gregora, Evzen and Pour, Ludek and Scudla, Vlastimil and Spicka, Ivan and Abildgaard, Niels and Andersen, Niels and Jensen, Bo Amdi and Helleberg, Carsten and Plesner, Torben and Salomo, Morten and Svirskaite, Asta and Delarue, Richard and Blau, Igor and Schieferdecker, Aneta and Teleanu, Veronica and Munder, Markus and Rollig, Christoph and Salwender, Han-Juergen and Fuhrmann, Stephan and Weisel, Katja and Duerig, Jan and Zeis, Matthias and Klein, Stefan and Reimer, Peter and Schmidt, Christian and Scheid, Christof and Mayer, Karin and Hoffmann, Martin and Sosada, Markus and Dimopoulos, Athanasios and Delimpasi, Sosana and Kyrtsonis, Mary-Christine and Anagnostopoulos, Achilleas and Nagy, Zsolt and Illes, Arpad and Egyed, Miklos and Borbenyi, Zita and Mikala, Gabor and Dally, Najib and Horowitz, Netanel and Gutwein, Odit and Nemets, Anatoly and Vaxman, Iuliana and Shvetz, Olga and Trestman, Svetlana and Ruchlemer, Rosa and Nagler, Arnon and Tadmor, Tamar and Rouvio, Ory and Preis, Meir and Cavo, Michele and De Rosa, Luca and ...
Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, p. 253
Background Maintenance therapy following autologous stem cell transplantation (ASCT) can delay disease progression and prolong survival in patients with... 
Journal Article
by Usmani, Saad Zafar and Schjesvold, Fredrik and Oriol, Albert and Karlin, Lionel and Cavo, Michele and Rifkin, Robert M and Rifkin, Robert and Yimer, Habte and Yimer, Habte Aragaw and LeBlanc, Richard and Takezako, Naoki and McCroskey, Robert Donald and McCroskey, Robert and Lim, Andrew Boon Ming and Lim, Andrew and Suzuki, Kenshi and Kosugi, Hiroshi and Grigoriadis, George and Avivi, Irit and Facon, Thierry and Jagannath, Sundar and Lonial, Sagar and Ghori, Razi Uddin and Farooqui, Mohammed Z H and Marinello, Patricia and San-Miguel, Jesus and Walker, Trish and Nicol, Andrew and Reece, Donna and Elemary, Mohamed and Boudreault Pedneault, Jean Samuel and Attal, Michel and Weisel, Katja and Engelhardt, Monika and Mackensen, Andreas and Quinn, John and Cohen, Amos and Magen-Nativ, Hila and Benyamini, Noam and Larocca, Alessandra and Matsumoto, Morio and Iida, Shinsuke and Ishikawa, Takayuki and Kondo, Yukio and Sunami, Kazutaka and Ando, Kiyoshi and Teshima, Takanori and Chou, Takaaki and Iwasaki, Hiromi and Miki, Hirokazu and Matsumura, Itaru and Onishi, Yasushi and Izutsu, Koji and Kizaki, Masahiro and George, Anupkumar and Blacklock, Hillary and Simpson, David and Waage, Anders and Samoilova, Olga and Nikitin, Evgeniy and Chagorova, Tatiana and McDonald, Andrew and Patel, Moosa and Oriol Rocafiguera, Albert and San Miguel Izquierdo, Jesus and Mateos, Maria and Streetly, Matthew and Forsyth, Peter and Jackson, Graham and Jenkins, Stephen and Martincic, Danko and Tarantolo, Stefano and Larson, Sarah and Faroun, Yacoub and Vaughn, Jennifer and Baz, Rachid and Saylors, Gene and Neppalli, Amarendra and Raptis, Anastasios and Fung, Henry and Janosky, Maxwell and Stevens, Don and Coleman, Morton and Costa, Dennis and Cross, Scott and Fanning, Suzanne and Berges, Daniel Farray and Harris, Thomas and Zackon, Ira and Atanackovic, Djordje and Lee, Wes and Lee, Kelvin and Oliff, Ira and Bensinger, William and Lutzky, Jose and Baron, Ari and Hayek, Fadi and Kirschner, Eli and Bharany, Neeraj and Overton, Lindsay and ... and KEYNOTE-185 Investigators
The Lancet Haematology, ISSN 2352-3026, 09/2019, Volume 6, Issue 9, pp. e448 - e458
Lenalidomide and dexamethasone has been a standard of care in transplant-ineligible patients with newly diagnosed multiple myeloma. The addition of a third... 
CELLS | PREDNISONE | BORTEZOMIB | BLOCKADE | HEMATOLOGY | EXPRESSION | MELPHALAN
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 295 - 295
Abstract Abstract 295 Genetic events mediating transformation from the pre-malignant monoclonal gammopathies (MG) to myeloma (MM) are unknown. Previous FISH... 
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 3045 - 3045
Abstract Abstract 3045 Background: Lenalidomide is an oral IMiD® immunomodulatory compound with a dual mechanism of action, namely tumoricidal and... 
Journal Article
Journal Article